Tara Bancroft
Stock Analyst at TD Cowen
(1.90)
# 2,977
Out of 5,135 analysts
10
Total ratings
50%
Success rate
4.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $11.56 | +194.12% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $6.88 | +190.70% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $73.06 | +9.50% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $29.23 | +71.06% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $82.99 | -21.68% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.94 | +415.46% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $5.38 | - | 1 | Aug 31, 2022 |
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $11.56
Upside: +194.12%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $6.88
Upside: +190.70%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $73.06
Upside: +9.50%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $29.23
Upside: +71.06%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $82.99
Upside: -21.68%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $5.38
Upside: -